87 related articles for article (PubMed ID: 9891484)
1. A humanized single-chain Fv fragment with high targeting potential against human malignant gliomas.
Ohtomo T; Kawata H; Sekimori Y; Shimizu K; Kishima H; Moriuchi S; Miyao Y; Akamatsu K; Tsuchiya M
Anticancer Res; 1998; 18(6A):4311-5. PubMed ID: 9891484
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
Raso V; Ritz J; Basala M; Schlossman SF
Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of ricin A chain-containing immunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's disease.
Engert A; Burrows F; Jung W; Tazzari PL; Stein H; Pfreundschuh M; Diehl V; Thorpe P
Cancer Res; 1990 Jan; 50(1):84-8. PubMed ID: 2152774
[TBL] [Abstract][Full Text] [Related]
4. [Selective cytotoxic effect of an immunotoxin on human erythroid tumor cells].
Tonevitskiĭ AG; Agapov II; Mechetner EB
Mol Biol (Mosk); 1991; 25(5):1181-7. PubMed ID: 1753950
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the cytotoxic potency of T101 Fab, F(ab')2 and whole IgG immunotoxins.
Derocq JM; Casellas P; Laurent G; Ravel S; Vidal H; Jansen F
J Immunol; 1988 Oct; 141(8):2837-43. PubMed ID: 3262669
[TBL] [Abstract][Full Text] [Related]
6. Construction and characterization of human CD7-specific single-chain Fv immunotoxins.
Pauza ME; Doumbia SO; Pennell CA
J Immunol; 1997 Apr; 158(7):3259-69. PubMed ID: 9120282
[TBL] [Abstract][Full Text] [Related]
7. Comparison of recombinant immunotoxins against LeY antigen expressing tumor cells: influence of affinity, size, and stability.
Bera TK; Pastan I
Bioconjug Chem; 1998; 9(6):736-43. PubMed ID: 9815167
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the cytotoxic activity of the immunotoxins with different internalization rate.
Tonevitsky AG; Agapov II; Mechetner EB; Ershova GV; Toptygin AYu ; Sarma T; Shamshiev AT; Pfueller U
Biochem Mol Biol Int; 1993 Dec; 31(6):1059-69. PubMed ID: 8193589
[TBL] [Abstract][Full Text] [Related]
10. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
[TBL] [Abstract][Full Text] [Related]
11. Internalization with high targeting potential of mouse monoclonal antibody ONS-M21 recognizing human malignant glioma antigen.
Shimizu K; Park KC; Tamura K; Kishima H; Kawata H; Yoshimura Y; Sekimori Y; Miyao Y; Hayakawa T
Cancer Lett; 1998 May; 127(1-2):171-6. PubMed ID: 9619874
[TBL] [Abstract][Full Text] [Related]
12. A bivalent single-chain Fv fragment against CD47 induces apoptosis for leukemic cells.
Kikuchi Y; Uno S; Yoshimura Y; Otabe K; Iida S; Oheda M; Fukushima N; Tsuchiya M
Biochem Biophys Res Commun; 2004 Mar; 315(4):912-8. PubMed ID: 14985099
[TBL] [Abstract][Full Text] [Related]
13. Production of functionalized single-chain Fv antibody fragments binding to the ED-B domain of the B-isoform of fibronectin in Pichia pastoris.
Marty C; Scheidegger P; Ballmer-Hofer K; Klemenz R; Schwendener RA
Protein Expr Purif; 2001 Feb; 21(1):156-64. PubMed ID: 11162401
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
Wang X; Campoli M; Ko E; Luo W; Ferrone S
J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody ONS-M21 recognizes integrin alpha3 in gliomas and medulloblastomas.
Kishima H; Shimizu K; Tamura K; Miyao Y; Mabuchi E; Tominaga E; Matsuzaki J; Hayakawa T
Br J Cancer; 1999 Jan; 79(2):333-9. PubMed ID: 9888477
[TBL] [Abstract][Full Text] [Related]
16. Specific cytotoxicity of a human immunoglobulin-directed Fab'-ricin A chain conjugate.
Raso V; Griffin T
J Immunol; 1980 Dec; 125(6):2610-6. PubMed ID: 7430640
[TBL] [Abstract][Full Text] [Related]
17. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
Wang Y; Li X; Chen W
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
[TBL] [Abstract][Full Text] [Related]
18. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
[TBL] [Abstract][Full Text] [Related]
19. [Construction and expression of single chain Fv antibody against human bladder carcinoma].
Zhang M; Yu L; Huang H
Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):792-5. PubMed ID: 16201198
[TBL] [Abstract][Full Text] [Related]
20. Toxicity of a monoclonal F(ab')2:ricin A conjugate for retinoblastoma in vitro.
Merriam JC; Lyon HS; Char DH
Cancer Res; 1984 Aug; 44(8):3178-83. PubMed ID: 6744258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
